Prostate Cancer

Prostate screening looks for prostate-specific antigen (PSA) in the blood and may include a digital rectal exam (DRE). Talk with your clinician about when to start, because benefits depend on your age, family history, and personal values.

Average risk: discuss PSA/DRE between ages 50-69
Higher risk (Black men or strong family history): start the conversation at 40-45
Screening can pause after age 70 if PSA is consistently low

*Risk shortcuts

Average risk: no prostate cancer in close relatives, no known BRCA or similar mutations, and no concerning PSA history
Higher risk: Black men, strong family history, or known gene mutations—discuss starting at 40-45 and repeat tests more often

PSA Blood Test

Measures the level of PSA protein. A value above 4 ng/mL may prompt repeat testing, MRI, or a biopsy depending on trends and risk.

Digital Rectal Exam

A clinician gently checks for bumps or firmness on the prostate. When combined with PSA, it increases the chance of finding aggressive disease early.

MRI & Biopsy

If PSA stays elevated, MRI helps pinpoint suspicious areas. Image-guided biopsies then confirm whether cancer is present and how aggressive it is.

Lifestyle & Prevention

Balanced nutrition, regular exercise, and quitting smoking support prostate health. If you’re on testosterone therapy, check PSA more frequently.

Discuss These Symptoms

Weak urine stream or frequent nighttime urination
Blood in urine or semen
Pelvic discomfort, lower back pain, or unexplained weight loss